Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Current Assets (2019 - 2025)

Historic Current Assets for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $245.6 million.

  • Pliant Therapeutics' Current Assets fell 4010.5% to $245.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.6 million, marking a year-over-year decrease of 4010.5%. This contributed to the annual value of $362.3 million for FY2024, which is 2833.58% down from last year.
  • As of Q3 2025, Pliant Therapeutics' Current Assets stood at $245.6 million, which was down 4010.5% from $267.4 million recorded in Q2 2025.
  • In the past 5 years, Pliant Therapeutics' Current Assets ranged from a high of $588.2 million in Q1 2023 and a low of $173.5 million during Q2 2022
  • Its 5-year average for Current Assets is $355.4 million, with a median of $340.3 million in 2022.
  • As far as peak fluctuations go, Pliant Therapeutics' Current Assets soared by 22600.36% in 2023, and later tumbled by 4024.31% in 2025.
  • Pliant Therapeutics' Current Assets (Quarter) stood at $209.4 million in 2021, then soared by 62.49% to $340.3 million in 2022, then soared by 48.54% to $505.5 million in 2023, then fell by 28.34% to $362.3 million in 2024, then crashed by 32.21% to $245.6 million in 2025.
  • Its Current Assets was $245.6 million in Q3 2025, compared to $267.4 million in Q2 2025 and $311.2 million in Q1 2025.